NCT04966923View on ClinicalTrials.gov

Phenotype and Prognosis of Patients With Breast Cancer and Pathogenic Variants of TP53

CompletedOBSERVATIONAL
Enrollment

135

Participants

Timeline

Start Date

December 2, 2018

Primary Completion Date

August 7, 2021

Study Completion Date

February 22, 2022

Conditions
Breast CancerTP53 R337HLi-Fraumeni SyndromePrognosis Breast Cancer
Interventions
OTHER

No intervention in this study

Analyses of pathogenic variant TP53 and variants in genetic test

Trial Locations (1)

01.246-000

ICESP, São Paulo

All Listed Sponsors
lead

Instituto do Cancer do Estado de São Paulo

OTHER

NCT04966923 - Phenotype and Prognosis of Patients With Breast Cancer and Pathogenic Variants of TP53 | Biotech Hunter | Biotech Hunter